Infants born to women who received a COVID-19 vaccine shortly before or during pregnancy did not have higher rates of any of 13 health outcomes than prepandemic national benchmarks, according to a CDC analysis published in the Journal of Pediatric Health Care.
The study drew on the COVID-19 Vaccine Pregnancy Registry, which enrolled pregnant women who received a COVID-19 vaccine between December 2020 and June 2021. Participants were interviewed at least three times about their infants' health through three months after birth, and a subsample was followed through 15 months.
